ReP USP - Resultado da busca

Artigo de periodico
P2X7 receptor isoform B is a key drug resistance mediator for neuroblastoma (2022)
Sampaio, Vanessa Fernandes Arnaud ; Bento, Carolina Adriane ; Glaser, Talita ; Adinolfi, Elena ; Ulrich, Henning ; Lameu, Claudiana
Source: Frontiers in Oncology. Unidade: IQ
Subjects: RECEPTORES, NEUROBLASTOMA, RESISTÊNCIA MICROBIANA ÀS DROGAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SAMPAIO, Vanessa Fernandes Arnaud et al. P2X7 receptor isoform B is a key drug resistance mediator for neuroblastoma. Frontiers in Oncology, v. 12, p. 1-19 art. 966404, 2022Tradução . . Disponível em: https://doi.org/10.3389/fonc.2022.966404. Acesso em: 03 nov. 2024.
APA
Sampaio, V. F. A., Bento, C. A., Glaser, T., Adinolfi, E., Ulrich, H., & Lameu, C. (2022). P2X7 receptor isoform B is a key drug resistance mediator for neuroblastoma. Frontiers in Oncology, 12, 1-19 art. 966404. doi:10.3389/fonc.2022.966404
NLM
Sampaio VFA, Bento CA, Glaser T, Adinolfi E, Ulrich H, Lameu C. P2X7 receptor isoform B is a key drug resistance mediator for neuroblastoma [Internet]. Frontiers in Oncology. 2022 ; 12 1-19 art. 966404.[citado 2024 nov. 03 ] Available from: https://doi.org/10.3389/fonc.2022.966404
Vancouver
Sampaio VFA, Bento CA, Glaser T, Adinolfi E, Ulrich H, Lameu C. P2X7 receptor isoform B is a key drug resistance mediator for neuroblastoma [Internet]. Frontiers in Oncology. 2022 ; 12 1-19 art. 966404.[citado 2024 nov. 03 ] Available from: https://doi.org/10.3389/fonc.2022.966404
Artigo de periodico
Cancer metabostemness and metabolic reprogramming via P2X7 receptor (2021)
Rabelo, Izadora Lorrany Alves; Sampaio, Vanessa Fernandes Arnaud ; Adinolfi, Elena ; Ulrich, Henning ; Lameu, Claudiana
Source: Cells. Unidade: IQ
Subjects: CÉLULAS-TRONCO, NEOPLASIAS, RECEPTORES, METÁSTASE NEOPLÁSICA, METABOLISMO, QUIMIOTERAPIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RABELO, Izadora Lorrany Alves et al. Cancer metabostemness and metabolic reprogramming via P2X7 receptor. Cells, v. 10, p. 1-15 art. 1782, 2021Tradução . . Disponível em: https://doi.org/10.3390/cells10071782. Acesso em: 03 nov. 2024.
APA
Rabelo, I. L. A., Sampaio, V. F. A., Adinolfi, E., Ulrich, H., & Lameu, C. (2021). Cancer metabostemness and metabolic reprogramming via P2X7 receptor. Cells, 10, 1-15 art. 1782. doi:10.3390/cells10071782
NLM
Rabelo ILA, Sampaio VFA, Adinolfi E, Ulrich H, Lameu C. Cancer metabostemness and metabolic reprogramming via P2X7 receptor [Internet]. Cells. 2021 ; 10 1-15 art. 1782.[citado 2024 nov. 03 ] Available from: https://doi.org/10.3390/cells10071782
Vancouver
Rabelo ILA, Sampaio VFA, Adinolfi E, Ulrich H, Lameu C. Cancer metabostemness and metabolic reprogramming via P2X7 receptor [Internet]. Cells. 2021 ; 10 1-15 art. 1782.[citado 2024 nov. 03 ] Available from: https://doi.org/10.3390/cells10071782
Trabalho de evento-resumo periodico
P2X7B isoform role in chemoresistance and epithelial-tomesenchymal transition of human neuroblastoma cells (2019)
Sampaio, Vanessa Fernandes Arnaud; Rabelo, Isadora Lorrany Alves; Glaser, Talita; Ulrich, Henning ; Adinolfi, Elena; Lameu, Claudiana
Source: Purinergic Signalling. Conference titles: International Basic and Translational Science on Purinergic Signaling and its Components for a Health and Better World/PURINES. Unidade: IQ
Subjects: NEUROBLASTOMA, CÉLULAS EPITELIAIS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SAMPAIO, Vanessa Fernandes Arnaud et al. P2X7B isoform role in chemoresistance and epithelial-tomesenchymal transition of human neuroblastoma cells. Purinergic Signalling. Dordrecht: Instituto de Química, Universidade de São Paulo. Disponível em: https://doi.org/10.1007/s11302-018-9637-0. Acesso em: 03 nov. 2024. , 2019
APA
Sampaio, V. F. A., Rabelo, I. L. A., Glaser, T., Ulrich, H., Adinolfi, E., & Lameu, C. (2019). P2X7B isoform role in chemoresistance and epithelial-tomesenchymal transition of human neuroblastoma cells. Purinergic Signalling. Dordrecht: Instituto de Química, Universidade de São Paulo. doi:10.1007/s11302-018-9637-0
NLM
Sampaio VFA, Rabelo ILA, Glaser T, Ulrich H, Adinolfi E, Lameu C. P2X7B isoform role in chemoresistance and epithelial-tomesenchymal transition of human neuroblastoma cells [Internet]. Purinergic Signalling. 2019 ; 14 S68.[citado 2024 nov. 03 ] Available from: https://doi.org/10.1007/s11302-018-9637-0
Vancouver
Sampaio VFA, Rabelo ILA, Glaser T, Ulrich H, Adinolfi E, Lameu C. P2X7B isoform role in chemoresistance and epithelial-tomesenchymal transition of human neuroblastoma cells [Internet]. Purinergic Signalling. 2019 ; 14 S68.[citado 2024 nov. 03 ] Available from: https://doi.org/10.1007/s11302-018-9637-0
Trabalho de evento-resumo periodico
Bradykinin effects on P2X7 isoforms to regulate stemness and cell invasion in neuroblastoma (2019)
Rabelo, Isadora Lorrany Alves; Glaser, Talita; Ulrich, Henning ; Adinolfi, Elena; Lameu, Claudiana
Source: Purinergic Signalling. Conference titles: International Basic and Translational Science on Purinergic Signaling and its Components for a Health and Better World/PURINES. Unidade: IQ
Assunto: NEUROBLASTOMA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RABELO, Isadora Lorrany Alves et al. Bradykinin effects on P2X7 isoforms to regulate stemness and cell invasion in neuroblastoma. Purinergic Signalling. Dordrecht: Instituto de Química, Universidade de São Paulo. Disponível em: https://doi.org/10.1007/s11302-018-9637-0. Acesso em: 03 nov. 2024. , 2019
APA
Rabelo, I. L. A., Glaser, T., Ulrich, H., Adinolfi, E., & Lameu, C. (2019). Bradykinin effects on P2X7 isoforms to regulate stemness and cell invasion in neuroblastoma. Purinergic Signalling. Dordrecht: Instituto de Química, Universidade de São Paulo. doi:10.1007/s11302-018-9637-0
NLM
Rabelo ILA, Glaser T, Ulrich H, Adinolfi E, Lameu C. Bradykinin effects on P2X7 isoforms to regulate stemness and cell invasion in neuroblastoma [Internet]. Purinergic Signalling. 2019 ; 14 S91.[citado 2024 nov. 03 ] Available from: https://doi.org/10.1007/s11302-018-9637-0
Vancouver
Rabelo ILA, Glaser T, Ulrich H, Adinolfi E, Lameu C. Bradykinin effects on P2X7 isoforms to regulate stemness and cell invasion in neuroblastoma [Internet]. Purinergic Signalling. 2019 ; 14 S91.[citado 2024 nov. 03 ] Available from: https://doi.org/10.1007/s11302-018-9637-0
Artigo de periodico
Kinin and purine signaling contributes to neuroblastoma metastasis (2018)
Ulrich, Henning ; Ratajczak, Mariusz; Schneider, Gabriela; Adinolfi, Elena; Orioli, Elisa; Ferrazoli, Enéas Galdini; Glaser, Talita; Velloso, Juliana Correa; Martins, Poliana Cristina de Melo; Coutinho, Fernanda; Santos, Ana Paula de Jesus; Pillat, Micheli Mainardi; Sack, Ulrich; Lameu, Claudiana
Source: Frontiers in Pharmacology. Unidade: IQ
Subjects: CÉLULAS-TRONCO, NEUROBLASTOMA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ULRICH, Henning et al. Kinin and purine signaling contributes to neuroblastoma metastasis. Frontiers in Pharmacology, v. 9, p. 1-17 art. 500, 2018Tradução . . Disponível em: https://doi.org/10.3389/fphar.2018.00500. Acesso em: 03 nov. 2024.
APA
Ulrich, H., Ratajczak, M., Schneider, G., Adinolfi, E., Orioli, E., Ferrazoli, E. G., et al. (2018). Kinin and purine signaling contributes to neuroblastoma metastasis. Frontiers in Pharmacology, 9, 1-17 art. 500. doi:10.3389/fphar.2018.00500
NLM
Ulrich H, Ratajczak M, Schneider G, Adinolfi E, Orioli E, Ferrazoli EG, Glaser T, Velloso JC, Martins PC de M, Coutinho F, Santos AP de J, Pillat MM, Sack U, Lameu C. Kinin and purine signaling contributes to neuroblastoma metastasis [Internet]. Frontiers in Pharmacology. 2018 ; 9 1-17 art. 500.[citado 2024 nov. 03 ] Available from: https://doi.org/10.3389/fphar.2018.00500
Vancouver
Ulrich H, Ratajczak M, Schneider G, Adinolfi E, Orioli E, Ferrazoli EG, Glaser T, Velloso JC, Martins PC de M, Coutinho F, Santos AP de J, Pillat MM, Sack U, Lameu C. Kinin and purine signaling contributes to neuroblastoma metastasis [Internet]. Frontiers in Pharmacology. 2018 ; 9 1-17 art. 500.[citado 2024 nov. 03 ] Available from: https://doi.org/10.3389/fphar.2018.00500

USP Schools

ReP

Filtros

Authors

USP affiliated authors

Subjects

Funding Agencies